Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
REGENERON PHARMACEUTICALS, INC. | Director | Common Stock | 282 | $268K | $951.26 | Jan 2, 2024 | Direct |
REGENERON PHARMACEUTICALS, INC. | Director | Non-Qualified Stock Option (right to buy) | 508 | Jan 2, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
REGN | REGENERON PHARMACEUTICALS, INC. | Jan 2, 2024 | 2 | $0 | 4 | Jan 4, 2024 | Director |
REGN | REGENERON PHARMACEUTICALS, INC. | Sep 8, 2023 | 2 | $0 | 4 | Sep 12, 2023 | Director |
REGN | REGENERON PHARMACEUTICALS, INC. | Sep 8, 2023 | 0 | $0 | 3 | Sep 12, 2023 | Director |